Literature DB >> 21647179

Therapy: antisense inhibitor of apo B has potent lipoprotein effects.

Bryony M Mearns.   

Abstract

Year:  2011        PMID： 21647179     DOI： 10.1038/nrcardio.2011.88

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN： 1759-5002            Impact factor:   32.419


× No keyword cloud information.
  1 in total

1.  Efficacy of apolipoprotein B synthesis inhibition in subjects with mild-to-moderate hyperlipidaemia.

Authors:  Fatima Akdim; Diane L Tribble; JoAnn D Flaim; Rosie Yu; John Su; Richard S Geary; Brenda F Baker; Rainard Fuhr; Mark K Wedel; John J P Kastelein
Journal:  Eur Heart J       Date:  2011-05-18       Impact factor: 29.983
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.